Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Margarete A. Fabre, Joseph Vijai et al.|Nature Communications|2025Cited by 14
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Margarete A. Fabre, Niedzica Camacho et al.|medRxiv|2024Cited by 4